Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Masayuki Ashikari is active.

Publication


Featured researches published by Masayuki Ashikari.


American Journal of Ophthalmology | 2003

Retention of dye after indocyanine Green-assisted internal limiting membrane peeling ☆

Masayuki Ashikari; Hironori Ozeki; Kazuyuki Tomida; Eiji Sakurai; Kazushi Tamai; Yuichiro Ogura

PURPOSE To describe the long-term retention of indocyanine green (ICG) in the fundus after ICG-assisted internal limiting membrane peeling. DESIGN Case report. Two patients underwent vitrectomy including ICG-assisted internal limiting membrane peeling. The fundus was examined with a 780-nm infrared illumination of a scanning laser ophthalmoscope after surgery. RESULTS No ICG staining of the fundus was visible ophthalmoscopically. Examination with a scanning laser ophthalmoscope, however, detected fluorescence from residual ICG until 6 months after surgery in case 1 and 9 months in case 2. No complication related to the residual ICG was observed. CONCLUSIONS The results suggested that ICG remains in the fundus for a long period after surgery. Clearance of the dye from the diabetic retina may be prolonged.


Graefes Archive for Clinical and Experimental Ophthalmology | 2000

Ocular and systemic features of Peters' anomaly.

Hironori Ozeki; Shoichiro Shirai; Miho Nozaki; Eiji Sakurai; Shinichi Mizuno; Masayuki Ashikari; Noriko Matsunaga; Yuichiro Ogura

Abstract Background: To clarify the relationship between associated systemic anomalies and ocular manifestations in patients with Peters’ anomaly, a retrospective study was conducted. Methods: We classified 37 patients with Peters’ anomaly into two groups, one with (+) and one without (–) systemic anomalies. Results: The systemic anomaly (+) group consisted of 13 patients, eight males and five females, with mean age of 2.3 months. Peters’ anomaly was bilateral in six cases and unilateral in seven. Corneolenticular adhesion was observed in 11 cases. Associated ocular anomalies were seen in 12 cases, and developmental glaucoma was present in eight cases. The systemic anomaly (–) group comprised 24 patients, 13 males and 11 females, with mean age of 28.3 months. Peters’ anomaly was bilateral in 11 cases and unilateral in 13. Corneolenticular adhesion was observed in five cases. The associated ocular anomalies were observed in 10 cases, and developmental glaucoma was accompanied in six cases. The incidences of cases with corneolenticular adhesion, those with other ocular anomalies, and those with glaucoma were significantly higher in the systemic anomaly (+) group than in the systemic anomaly (–) group. Conclusions: Peters’ anomaly accompanying corneolenticular adhesion and/or other ocular anomalies should be evaluated for the presence of systemic anomalies.


Investigative Ophthalmology & Visual Science | 2010

Suppression of Laser-Induced Choroidal Neovascularization by Nontargeted siRNA

Masayuki Ashikari; M. Tokoro; M. Itaya; Miho Nozaki; Yuichiro Ogura

PURPOSE. To investigate the effect of nontargeted siRNAs on vascular leakage and vascular endothelial growth factor (VEGF)-A expression in the development of choroidal neovascularization (CNV). METHODS. Nontargeted siRNAs were 21-nt (nucleotides) siRNA-Luc (Luciferase) or 16-nt siRNA-Luc. Targeted 21-nt siRNA-Vegfa or phosphate-buffered saline (PBS) was used for comparison. Laser photocoagulation was used to induce CNV in wild-type C57BL/6J mice; 7 days later, vascular leakage was determined by fluorescein angiography, and CNV volumes were measured by confocal microscopy. Expression of VEGF-A in the retinal pigment epithelium (RPE)/choroid was quantified by ELISA 3 days after photocoagulation. RESULTS. Pathologically significant leakage developed in most of the 16nt-siRNA-Luc- or PBS-injected mice but in significantly fewer 21nt-siRNA-Luc- and 21nt-siRNA-Vegfa-injected mice (P = 0.0004, P = 0.0001, respectively). CNV volume in 21-nt siRNA-Luc- and 21nt-siRNA-Vegfa-injected eyes was significantly lower than in PBS-injected eyes (P = 0.0124, P = 0.0040, respectively). CNV volume was not suppressed by 16-nt siRNA-Luc injection (P = 0.7700). The mean VEGF protein level decreased significantly in the 21nt-siRNA-Luc- and 21nt-siRNA-Vegfa-injected eyes compared with PBS-injected eyes 3 days after laser photocoagulation (P = 0.0011, P = 0.0063, respectively). The 16nt-siRNA-Luc-injected eyes did not show VEGF-A suppression 3 days after laser photocoagulation (P = 0.3177). Between 21-nt siRNA-Luc- and 21nt-siRNA-Vegfa-injected eyes, there were no significant differences in CNV volume, the VEGF-A level, or pathologic leakage detected by fluorescein. CONCLUSIONS. These data suggest that nontarget 21nt-siRNA can suppress laser-induced choroidal neovascularization anatomically and functionally through VEGF suppression.


Japanese Journal of Ophthalmology | 2006

Long-term retention of dye after indocyanine green-assisted internal limiting membrane peeling.

Masayuki Ashikari; Hironori Ozeki; Kazuyuki Tomida; Eiji Sakurai; Kazushi Tamai; Yuichiro Ogura

PurposeTo evaluate dye retention in the fundus after indocyanine green (ICG)-assisted internal limiting membrane peeling.MethodsTen eyes with stage 3 or 4 nondiabetic idiopathic macular hole (MH group) and six eyes with diffuse diabetic macular edema (DM group) were studied. The fundus was examined with 780-nm infrared illumination by a scanning laser ophthalmoscope (SLO) after ICG-assisted internal limiting membrane peeling. The postoperative follow-up period ranged from 6 to 12 months (mean ± SD, 3.7 ± 2.6 months).ResultsFluorescence from ICG was detected in all studied eyes in both groups up to 6 months after surgery. At 9 months after surgery, ICG fluorescence was visible in all eyes of the DM group, but in only one-third of eyes of the MH group. No fluorescence was detected in fellow eyes that had not been operated on.ConclusionThe present study using SLO revealed that ICG remains in the fundus for over 6 months after surgery. The results also suggested that a longer time might be required for dye clearance from the diabetic retina than from the nondiabetic retina. Jpn J Ophthalmol 2006;50:349–353


Ophthalmic Research | 2015

Short pulse laser induces less inflammatory cytokines in the murine retina after laser photocoagulation.

Aiko Ito; Yoshio Hirano; Miho Nozaki; Masayuki Ashikari; Kazuhiko Sugitani; Yuichiro Ogura

Aims: The purpose of this study was to evaluate the effect of pulse duration on the expression of inflammatory cytokines in the murine retina after laser photocoagulation treatment with a PASCAL® pattern scan laser photocoagulator and conventional laser treatment. Methods: Retinal scatter laser photocoagulation was performed on C57BL/6J mice using a short pulse (10 ms) with a PASCAL laser or conventional settings (100 ms) with a multicolor laser. Eyes were enucleated before treatment (control) and 1 day, 3 days and 7 days after treatment. The levels of inflammatory cytokines (i.e., VEGF, MCP-1, RANTES and IL-6) in the retina/choroid were quantified by an ELISA. The expression patterns of VEGF and macrophages (i.e., F4/80) in the retina/choroid were evaluated by immunohistochemistry. Results: The levels of RANTES, IL-6 and MCP-1 after PASCAL and conventional laser treatments were significantly elevated compared with controls (p < 0.05). Conventional laser treatment, but not PASCAL treatment, resulted in the up-regulation of VEGF. RANTES and IL-6 levels on day 1 and MCP-1 levels on day 3 in the sensory retina were also significantly up-regulated with conventional laser treatment compared with PASCAL treatment (p < 0.05). Immunohistochemical analysis showed that PASCAL treatment was associated with lower VEGF and F4/80 expression levels compared with conventional laser treatment. Conclusions: Our data suggested that the short pulse duration induced fewer inflammatory cytokines in the sensory retina compared with the conventional pulse duration. Short pulse laser photocoagulation with the PASCAL may prevent macular edema after panretinal photocoagulation.


Ophthalmologica | 2013

Efficient delivery of siRNA by atelocollagen in a murine laser-induced choroidal neovascularization model.

Yuya Ito; Miho Nozaki; Kazuhiko Sugitani; Masayuki Ashikari; Yoshio Hirano; Yuichiro Ogura

Purpose: Previous studies have shown that small interfering RNAs (siRNAs) could suppress angiogenesis via stimulation of toll-like receptor-3 (TLR3). The purpose of this study was to determine the efficacy of atelocollagen to deliver siRNA without TLR3 stimulation in the laser-induced choroidal neovascularization (CNV) model. Methods: CNV was induced by laser injury in C57BL/6J mice and volumes were measured 7 days later. Nontargeted siRNA, 21-nucleotide (nt) siRNA-Luc (Luciferase) and 21-nt siRNA-Vegfa were injected into the vitreous following injury. Atelocollagen was incubated with naked 21-nt siRNAs before injection. To block TLR3 endosomal activity, chloroquine was injected intravitreously after laser injury. Results: The mean CNV volumes were significantly smaller in the naked siRNA-Luc, naked siRNA-Vegfa, or siRNA-Vegfa/atelocollagen complex compared with PBS, atelocollagen or siRNA-Luc/atelocollagen complex-injected mice (p < 0.05). Conclusion: These findings demonstrate that atelocollagen may deliver siRNA without nonspecific TLR3 stimulation in the murine laser-CNV model.


British Journal of Ophthalmology | 2001

Histopathological examination of two cases of anterior staphyloma associated with Peters' anomaly and persistent hyperplastic primary vitreous

Akihisa Matsubara; Hironori Ozeki; Noriko Matsunaga; Miho Nozaki; Masayuki Ashikari; Shoichiro Shirai; Yuichiro Ogura


Investigative Ophthalmology & Visual Science | 2009

Non-Targeted siRNA Suppresses Laser-Induced Choroidal Neovascularization

Masayuki Ashikari; M. Tokoro; M. Itaya; Miho Nozaki; Yuichiro Ogura


Investigative Ophthalmology & Visual Science | 2014

Long-Term Impacts of Antioxidant Supplementation and Smoking Cessation on Chronic Central Serous Chorioretinopathy

Midori Araki; Tsutomu Yasukawa; Masayuki Ashikari; Aki Kato; Nana Tachi; Yoshio Hirano; Yuichiro Ogura


Ophthalmologica | 2013

Subject Index Vol. 230, 2013

Marc D. de Smet; Ashraf M. Gad Elkareem; Aeilko H. Zwinderman; Ioannis Papaefthymiou; Ioannis K. Petropoulos; George Mangioris; Efstratios Mendrinos; Constantin J. Pournaras; Francesco Bandello; Carlo La Spina; Lorenzo Iuliano; Giovanni Fogliato; Maurizio Battaglia Parodi; Isabel Pires; Ana Rita Santos; Sandrina Nunes; Conceição Lobo; José Cunha-Vaz; Mehmet Yasin Teke; Melike Balikoglu-Yilmaz; Pınar Yüksekkaya; Mehmet Citirik; Ufuk Elgin; Pinar Ozdal; Sule Yenigun; Emine Sen; Faruk Öztürk; Yuya Ito; Miho Nozaki; Kazuhiko Sugitani

Collaboration


Dive into the Masayuki Ashikari's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Miho Nozaki

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Yuya Ito

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

M. Itaya

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar

M. Tokoro

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar

Aiko Ito

Nagoya City University

View shared research outputs
Researchain Logo
Decentralizing Knowledge